Cargando…
Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus
BACKGROUND: Chronic low-grade inflammation is considered one of the major mechanisms for the progression of diabetic kidney disease. We investigated the prognostic value of circulating soluble tumor necrosis factor receptor 2 (sTNFR2) for early nephropathy in patients with type 2 diabetes. MATERIALS...
Autores principales: | Wu, Tsung-Hui, Chang, Li-Hsin, Chu, Chia-Huei, Hwu, Chii-Min, Chen, Harn-Shen, Lin, Liang-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004780/ https://www.ncbi.nlm.nih.gov/pubmed/35413081 http://dx.doi.org/10.1371/journal.pone.0266854 |
Ejemplares similares
-
The ankle brachial index exhibits better association with cardiovascular outcomes than interarm systolic blood pressure difference in patients with type 2 diabetes
por: Lin, Liang-Yu, et al.
Publicado: (2019) -
Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus
por: Chang, Li-Hsin, et al.
Publicado: (2023) -
Urinary acrolein protein conjugates-to-creatinine ratio is positively associated with diabetic peripheral neuropathy in patients with type 2 diabetes mellitus
por: Wu, Tsung-Hui, et al.
Publicado: (2023) -
Challenges of optimizing insulin therapy for patients with type 2 diabetes mellitus
por: Yen, Fu‐Shun, et al.
Publicado: (2021) -
Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus
por: Dande, Ranadheer R., et al.
Publicado: (2017)